Anthranilamide → HCID 67040389, compound

HRID 605104Notes

Reaction equation

[CH2:1]([O:8][C:9]1[CH:38]=[CH:37][C:12]([O:13][C:14]2[CH:22]=[CH:21][C:17]([C:18](Cl)=[O:19])=[CH:16][C:15]=2[NH:23][C:24]2[C:25]3[CH:33]=[CH:32][C:31]([CH:34]([CH3:36])[CH3:35])=[N:30][C:26]=3[N:27]=[CH:28][N:29]=2)=[CH:11][CH:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[NH2:39][C:40]1[CH:48]=[CH:47][CH:46]=[CH:45][C:41]=1[C:42]([NH2:44])=[O:43]>>[CH2:1]([O:8][C:9]1[CH:38]=[CH:37][C:12]([O:13][C:14]2[CH:22]=[CH:21][C:17]([C:18]([NH:39][C:40]3[CH:48]=[CH:47][CH:46]=[CH:45][C:41]=3[C:42](=[O:43])[NH2:44])=[O:19])=[CH:16][C:15]=2[NH:23][C:24]2[C:25]3[CH:33]=[CH:32][C:31]([CH:34]([CH3:36])[CH3:35])=[N:30][C:26]=3[N:27]=[CH:28][N:29]=2)=[CH:11][CH:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

Participants

Reactant 2

HCID 6942Anthranilamide

HCID 86615545HCID 86615545, compound

Product 1

HCID 67040389HCID 67040389, compound

Procedure

A solution of the product from Example 43D and 2-Amino-benzamide was reacted to provide 4-(4-Benzyloxy-phenoxy)-N-(2-carbamoyl-phenyl)-3-(7-isopropyl-pyrido[2,3-d]pyrimidin-4-ylamino)-benzamide using the procedure from Example 43E. The material was then deprotected using the procedure from Example 43F to provide the crude title compound which was purified by HPLC with TFA to provide the title compound as a trifluoroacetic acid salt (18 mg, 34%). 1H NMR (300 MHz, DMSO-D6) δ ppm: 1.35 (d, J=6.99 Hz, 6 H) 3.28 (m, 1 H) 6.76 (m, 2 H) 6.96 (m, 3 H) 7.18 (m, 1 H) 7.57 (m, 1 H) 7.85 (m, 4 H) 8.10 (d, J=2.21 Hz, 1 H) 8.43 (s, 1 H) 8.68 (d, J=8.46 Hz, 1 H) 8.91 (s, 1 H) 9.00 (d, J=8.82 Hz, 1 H) 9.48 (s, 1 H) 11.50 (s, 1 H) 12.99 (s, 1 H); MS (ESI+) m/z 535 (M+H)+.

Sources & evidence

ORD record: ord-96dcc2c3e8e14912b87e982f8d14c27d
Source dataset: uspto-grants-2011_03
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US07910595B2

Reaction notes

Loading…